Share Price and Basic Stock Data
Last Updated: January 15, 2026, 5:45 am
| PEG Ratio | 0.68 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ashok Leyland Ltd, a prominent player in the auto sector specializing in light commercial vehicles (LCVs) and heavy commercial vehicles (HCVs), reported a market capitalization of ₹1,09,665 Cr. The company’s revenue has shown significant growth, with sales rising from ₹26,237 Cr in FY 2022 to ₹41,673 Cr in FY 2023, and further to ₹45,703 Cr in FY 2024. The trailing twelve months (TTM) revenue stood at ₹50,976 Cr, indicating a robust upward trajectory. Quarterly sales figures also reflect this trend, with sales of ₹13,203 Cr in March 2023, followed by ₹11,429 Cr in September 2023, and projected sales of ₹14,696 Cr in March 2025. This consistent revenue growth underscores the company’s ability to capitalize on increasing demand in the commercial vehicle market, driven by economic recovery and infrastructure development. The company’s operational efficiency is further highlighted by the operating profit margin (OPM) which rose from 12% in FY 2022 to 19% in FY 2025, showcasing improved cost management and pricing power.
Profitability and Efficiency Metrics
Ashok Leyland’s profitability metrics demonstrate a strong performance, with net profit reaching ₹3,543 Cr in the latest reporting period. The company recorded a notable return on equity (ROE) of 28.8% and a return on capital employed (ROCE) of 14.3%, indicating effective utilization of shareholder funds and capital. Operating profit for the fiscal year ending March 2025 is projected at ₹9,208 Cr, with an operating profit margin (OPM) of 19.70%, reflecting the company’s operational efficiency. The interest coverage ratio (ICR) stood at 2.43x, suggesting that the company generates sufficient earnings to cover its interest expenses. However, while the company has maintained a positive trajectory, the net profit margin of 6.90% in FY 2025 indicates potential pressure on margins due to rising costs. Additionally, the cash conversion cycle (CCC) at -21 days underscores effective working capital management, allowing the company to quickly convert investments into cash.
Balance Sheet Strength and Financial Ratios
Ashok Leyland’s balance sheet reflects a mix of strength and challenges, with total borrowings amounting to ₹54,513 Cr against total reserves of ₹11,996 Cr. The equity capital remained stable at ₹294 Cr, while reserves increased significantly from ₹8,258 Cr in FY 2023 to ₹11,938 Cr in FY 2025, indicating a strengthening of the company’s net worth. The total liabilities stood at ₹81,546 Cr, with a debt-to-equity ratio of 4.06x, suggesting a high reliance on debt financing, which could pose risks if not managed properly. The current ratio stood at 1.29x, reflecting adequate short-term liquidity, while the quick ratio was slightly lower at 1.14x. The company’s book value per share increased to ₹41.66 in FY 2025, showcasing a growth in shareholder equity. However, the interest burden, as evidenced by rising interest expenses, could impact future profitability if not addressed. Overall, while the company has a solid asset base, the heavy reliance on debt remains a concern.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ashok Leyland indicates a stable ownership structure, with promoters holding 51.51% of the equity as of September 2025. Foreign institutional investors (FIIs) accounted for 24.32%, showing a significant increase from 15.29% in December 2022, which reflects growing investor confidence in the company’s prospects. Domestic institutional investors (DIIs) held 13.59%, while public shareholding accounted for 10.51%. The number of shareholders increased from 11,30,372 in December 2022 to 14,50,991 in September 2025, indicating a rising interest among retail investors. The consistent promoter holding, combined with increasing institutional interest, suggests a solid backing for the company. However, the decline in DIIs from 21.16% in December 2022 to 13.59% in September 2025 may signal a cautious outlook among domestic investors, which could be influenced by broader market conditions and sector-specific challenges.
Outlook, Risks, and Final Insight
Ashok Leyland appears well-positioned for continued growth, bolstered by robust revenue trends and strong operational metrics. Key strengths include a solid increase in sales and profitability, improved operational efficiency, and a stable shareholding pattern that reflects investor confidence. However, risks such as high leverage, potential pressure on profit margins from rising costs, and fluctuating demand in the commercial vehicle sector could pose challenges to sustained growth. The company’s ability to manage its debt levels while maintaining profitability will be crucial in the coming years. As market dynamics evolve, particularly with shifts towards electric vehicles and sustainability, Ashok Leyland’s adaptability will be critical. Should the company effectively navigate these challenges and capitalize on emerging opportunities, it could enhance its market position significantly. Conversely, failure to address these risks may hinder growth and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Force Motors Ltd | 27,005 Cr. | 20,495 | 22,000/6,125 | 32.9 | 2,661 | 0.20 % | 30.0 % | 20.8 % | 10.0 |
| SML Mahindra Ltd (SML ISUZU Ltd) | 6,446 Cr. | 4,455 | 4,745/1,028 | 45.6 | 307 | 0.40 % | 27.1 % | 36.4 % | 10.0 |
| Olectra Greentech Ltd | 9,149 Cr. | 1,115 | 1,714/974 | 64.0 | 137 | 0.04 % | 20.5 % | 14.3 % | 4.00 |
| Tata Motors Ltd | 1,47,974 Cr. | 402 | 538/324 | 6.84 | 316 | 1.49 % | 20.0 % | 28.1 % | 2.00 |
| Ashok Leyland Ltd | 1,09,776 Cr. | 187 | 192/95.2 | 32.8 | 21.4 | 1.67 % | 14.3 % | 28.8 % | 1.00 |
| Industry Average | 60,070.00 Cr | 5,330.80 | 36.43 | 688.48 | 0.76% | 22.38% | 25.68% | 5.40 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,600 | 10,400 | 13,203 | 9,691 | 11,429 | 11,093 | 13,542 | 10,724 | 11,148 | 11,995 | 14,696 | 11,709 | 12,577 |
| Expenses | 8,580 | 9,055 | 11,245 | 8,183 | 9,559 | 9,131 | 10,975 | 8,856 | 9,108 | 9,659 | 11,705 | 9,535 | 10,136 |
| Operating Profit | 1,020 | 1,344 | 1,958 | 1,509 | 1,870 | 1,961 | 2,567 | 1,868 | 2,040 | 2,336 | 2,991 | 2,173 | 2,441 |
| OPM % | 11% | 13% | 15% | 16% | 16% | 18% | 19% | 17% | 18% | 19% | 20% | 19% | 19% |
| Other Income | 32 | 36 | 97 | 53 | -1 | 46 | 10 | 36 | 245 | 75 | 22 | 103 | 103 |
| Interest | 499 | 545 | 582 | 655 | 715 | 783 | 829 | 904 | 962 | 1,011 | 1,053 | 1,112 | 1,152 |
| Depreciation | 209 | 220 | 259 | 227 | 227 | 241 | 233 | 235 | 244 | 268 | 340 | 273 | 268 |
| Profit before tax | 344 | 615 | 1,214 | 679 | 927 | 984 | 1,516 | 765 | 1,078 | 1,132 | 1,621 | 891 | 1,124 |
| Tax % | 46% | 43% | 34% | 14% | 39% | 38% | 38% | 28% | 29% | 28% | 23% | 26% | 27% |
| Net Profit | 186 | 351 | 803 | 584 | 569 | 609 | 934 | 551 | 767 | 820 | 1,246 | 658 | 820 |
| EPS in Rs | 0.28 | 0.54 | 1.28 | 0.93 | 0.90 | 0.95 | 1.45 | 0.87 | 1.20 | 1.30 | 1.92 | 1.04 | 1.29 |
Last Updated: January 13, 2026, 1:46 am
Below is a detailed analysis of the quarterly data for Ashok Leyland Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 12,577.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,709.00 Cr. (Jun 2025) to 12,577.00 Cr., marking an increase of 868.00 Cr..
- For Expenses, as of Sep 2025, the value is 10,136.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,535.00 Cr. (Jun 2025) to 10,136.00 Cr., marking an increase of 601.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 2,441.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,173.00 Cr. (Jun 2025) to 2,441.00 Cr., marking an increase of 268.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00%.
- For Other Income, as of Sep 2025, the value is 103.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 103.00 Cr..
- For Interest, as of Sep 2025, the value is 1,152.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,112.00 Cr. (Jun 2025) to 1,152.00 Cr., marking an increase of 40.00 Cr..
- For Depreciation, as of Sep 2025, the value is 268.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 273.00 Cr. (Jun 2025) to 268.00 Cr., marking a decrease of 5.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1,124.00 Cr.. The value appears strong and on an upward trend. It has increased from 891.00 Cr. (Jun 2025) to 1,124.00 Cr., marking an increase of 233.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 820.00 Cr.. The value appears strong and on an upward trend. It has increased from 658.00 Cr. (Jun 2025) to 820.00 Cr., marking an increase of 162.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.29. The value appears strong and on an upward trend. It has increased from 1.04 (Jun 2025) to 1.29, marking an increase of 0.25.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,859 | 15,708 | 21,260 | 22,871 | 29,636 | 33,197 | 21,951 | 19,454 | 26,237 | 41,673 | 45,703 | 48,535 | 50,976 |
| Expenses | 11,437 | 14,191 | 18,281 | 19,826 | 25,387 | 28,287 | 18,718 | 16,992 | 23,472 | 36,580 | 37,848 | 39,327 | 41,035 |
| Operating Profit | 422 | 1,517 | 2,979 | 3,045 | 4,248 | 4,910 | 3,233 | 2,462 | 2,765 | 5,093 | 7,856 | 9,208 | 9,942 |
| OPM % | 4% | 10% | 14% | 13% | 14% | 15% | 15% | 13% | 11% | 12% | 17% | 19% | 20% |
| Other Income | 613 | -106 | -321 | 406 | 190 | 139 | 57 | 207 | -230 | 166 | 160 | 405 | 304 |
| Interest | 805 | 872 | 925 | 1,049 | 1,227 | 1,502 | 1,802 | 1,901 | 1,869 | 2,094 | 2,982 | 3,930 | 4,328 |
| Depreciation | 530 | 580 | 524 | 573 | 646 | 676 | 750 | 836 | 866 | 900 | 927 | 1,087 | 1,149 |
| Profit before tax | -300 | -42 | 1,209 | 1,829 | 2,565 | 2,872 | 739 | -67 | -200 | 2,265 | 4,106 | 4,596 | 4,768 |
| Tax % | -23% | 415% | 41% | 11% | 29% | 24% | 38% | 4% | 43% | 40% | 34% | 26% | |
| Net Profit | -222 | -205 | 712 | 1,633 | 1,814 | 2,195 | 460 | -70 | -285 | 1,359 | 2,696 | 3,383 | 3,543 |
| EPS in Rs | -0.31 | 0.24 | 1.20 | 2.79 | 3.01 | 3.54 | 0.57 | -0.28 | -0.61 | 2.11 | 4.23 | 5.29 | 5.55 |
| Dividend Payout % | 0% | 96% | 40% | 28% | 40% | 44% | 44% | -107% | -82% | 62% | 59% | 59% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.66% | 447.32% | 129.35% | 11.08% | 21.00% | -79.04% | -115.22% | -307.14% | 576.84% | 98.38% | 25.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | 439.66% | -317.96% | -118.27% | 9.92% | -100.05% | -36.17% | -191.93% | 883.98% | -478.46% | -72.90% |
Ashok Leyland Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 54% |
| 3 Years: | 284% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 30% |
| 3 Years: | 16% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 15% |
| 3 Years: | 25% |
| Last Year: | 29% |
Last Updated: September 4, 2025, 11:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:58 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 266 | 285 | 285 | 285 | 293 | 294 | 294 | 294 | 294 | 294 | 294 | 294 | 587 |
| Reserves | 3,723 | 4,227 | 4,979 | 6,108 | 7,128 | 8,452 | 7,495 | 7,568 | 7,010 | 8,258 | 8,711 | 11,938 | 11,996 |
| Borrowings | 8,500 | 9,070 | 11,054 | 13,168 | 15,791 | 19,168 | 22,417 | 24,077 | 24,145 | 31,161 | 40,802 | 49,962 | 54,513 |
| Other Liabilities | 5,035 | 6,011 | 5,806 | 7,048 | 10,171 | 11,212 | 7,924 | 10,119 | 12,125 | 14,984 | 17,788 | 19,352 | 18,214 |
| Total Liabilities | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 | 85,310 |
| Fixed Assets | 7,573 | 6,529 | 5,890 | 6,591 | 6,596 | 6,695 | 8,031 | 8,484 | 7,895 | 8,146 | 8,157 | 8,837 | 9,499 |
| CWIP | 297 | 216 | 87 | 244 | 439 | 678 | 574 | 336 | 240 | 268 | 415 | 577 | 1,042 |
| Investments | 1,165 | 1,499 | 1,031 | 1,933 | 4,383 | 1,492 | 960 | 1,096 | 2,652 | 4,852 | 2,329 | 6,610 | 5,547 |
| Other Assets | 8,491 | 11,348 | 15,115 | 17,841 | 21,965 | 30,261 | 28,565 | 32,143 | 32,787 | 41,430 | 56,695 | 65,523 | 69,223 |
| Total Assets | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 | 85,310 |
Below is a detailed analysis of the balance sheet data for Ashok Leyland Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 587.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 293.00 Cr..
- For Reserves, as of Sep 2025, the value is 11,996.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,938.00 Cr. (Mar 2025) to 11,996.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2025, the value is 54,513.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 49,962.00 Cr. (Mar 2025) to 54,513.00 Cr., marking an increase of 4,551.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 18,214.00 Cr.. The value appears to be improving (decreasing). It has decreased from 19,352.00 Cr. (Mar 2025) to 18,214.00 Cr., marking a decrease of 1,138.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 85,310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81,546.00 Cr. (Mar 2025) to 85,310.00 Cr., marking an increase of 3,764.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 9,499.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,837.00 Cr. (Mar 2025) to 9,499.00 Cr., marking an increase of 662.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 577.00 Cr. (Mar 2025) to 1,042.00 Cr., marking an increase of 465.00 Cr..
- For Investments, as of Sep 2025, the value is 5,547.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,610.00 Cr. (Mar 2025) to 5,547.00 Cr., marking a decrease of 1,063.00 Cr..
- For Other Assets, as of Sep 2025, the value is 69,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 65,523.00 Cr. (Mar 2025) to 69,223.00 Cr., marking an increase of 3,700.00 Cr..
- For Total Assets, as of Sep 2025, the value is 85,310.00 Cr.. The value appears strong and on an upward trend. It has increased from 81,546.00 Cr. (Mar 2025) to 85,310.00 Cr., marking an increase of 3,764.00 Cr..
However, the Borrowings (54,513.00 Cr.) are higher than the Reserves (11,996.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 414.00 | -8.00 | -9.00 | -10.00 | -11.00 | -15.00 | -19.00 | -22.00 | -22.00 | -26.00 | -33.00 | -40.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 31 | 25 | 20 | 14 | 30 | 25 | 57 | 45 | 37 | 35 | 29 |
| Inventory Days | 69 | 58 | 50 | 73 | 42 | 52 | 42 | 76 | 53 | 44 | 50 | 49 |
| Days Payable | 116 | 108 | 71 | 85 | 96 | 88 | 90 | 162 | 150 | 96 | 85 | 99 |
| Cash Conversion Cycle | -5 | -19 | 5 | 8 | -39 | -6 | -22 | -30 | -52 | -16 | -0 | -21 |
| Working Capital Days | -45 | -41 | -23 | -21 | -54 | -13 | -31 | -44 | -52 | -34 | -50 | -37 |
| ROCE % | 8% | 17% | 15% | 17% | 16% | 9% | 5% | 6% | 11% | 15% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Large & Midcap Fund | 53,940,000 | 2.3 | 852.9 | 54,000,000 | 2025-12-15 07:28:09 | -0.11% |
| Nippon India Growth Mid Cap Fund | 51,844,304 | 1.95 | 819.76 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 41,080,000 | 2.17 | 649.56 | 39,000,000 | 2025-12-15 07:28:09 | 5.33% |
| HSBC Midcap Fund | 29,124,300 | 3.67 | 460.51 | N/A | N/A | N/A |
| SBI Flexicap Fund | 23,500,000 | 1.58 | 371.58 | N/A | N/A | N/A |
| HDFC Flexi Cap Fund | 20,500,000 | 0.34 | 324.15 | N/A | N/A | N/A |
| Franklin India Flexi Cap Fund | 17,710,254 | 1.4 | 280.03 | N/A | N/A | N/A |
| Kotak Multicap Fund | 16,515,000 | 1.17 | 261.14 | 17,835,000 | 2025-12-15 07:28:09 | -7.4% |
| Franklin India Focused Equity Fund | 14,300,000 | 1.76 | 226.11 | N/A | N/A | N/A |
| Axis Midcap Fund | 13,299,386 | 0.65 | 210.29 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| Diluted EPS (Rs.) | 10.56 | 8.45 | 4.22 | -1.22 | -0.56 |
| Cash EPS (Rs.) | 15.11 | 12.29 | 7.67 | 1.95 | 2.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Revenue From Operations / Share (Rs.) | 165.28 | 155.95 | 141.93 | 89.38 | 66.27 |
| PBDIT / Share (Rs.) | 32.58 | 27.53 | 17.72 | 9.72 | 8.84 |
| PBIT / Share (Rs.) | 28.88 | 24.37 | 14.66 | 6.77 | 5.99 |
| PBT / Share (Rs.) | 15.54 | 13.93 | 7.69 | -0.70 | -0.22 |
| Net Profit / Share (Rs.) | 11.41 | 9.13 | 4.60 | -0.99 | -0.23 |
| NP After MI And SOA / Share (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| PBDIT Margin (%) | 19.70 | 17.65 | 12.48 | 10.87 | 13.33 |
| PBIT Margin (%) | 17.47 | 15.62 | 10.32 | 7.56 | 9.03 |
| PBT Margin (%) | 9.40 | 8.93 | 5.41 | -0.78 | -0.34 |
| Net Profit Margin (%) | 6.90 | 5.85 | 3.24 | -1.11 | -0.35 |
| NP After MI And SOA Margin (%) | 6.40 | 5.42 | 2.97 | -1.36 | -0.84 |
| Return on Networth / Equity (%) | 25.39 | 27.58 | 14.50 | -4.90 | -2.10 |
| Return on Capital Employeed (%) | 15.37 | 17.46 | 13.33 | 7.94 | 6.80 |
| Return On Assets (%) | 3.80 | 3.67 | 2.26 | -0.82 | -0.39 |
| Long Term Debt / Equity (X) | 2.97 | 2.96 | 2.28 | 2.09 | 1.98 |
| Total Debt / Equity (X) | 4.06 | 4.51 | 3.61 | 3.28 | 2.31 |
| Asset Turnover Ratio (%) | 0.64 | 0.74 | 0.84 | 0.69 | 0.54 |
| Current Ratio (X) | 1.29 | 1.09 | 1.08 | 0.99 | 0.98 |
| Quick Ratio (X) | 1.14 | 0.94 | 0.92 | 0.86 | 0.82 |
| Inventory Turnover Ratio (X) | 12.14 | 7.58 | 9.45 | 6.96 | 6.04 |
| Dividend Payout Ratio (NP) (%) | 18.90 | 89.26 | 23.65 | -49.11 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.00 | 64.99 | 13.71 | 34.71 | 0.00 |
| Earning Retention Ratio (%) | 81.10 | 10.74 | 76.35 | 149.11 | 0.00 |
| Cash Earning Retention Ratio (%) | 86.00 | 35.01 | 86.29 | 65.29 | 0.00 |
| Interest Coverage Ratio (X) | 2.43 | 2.71 | 2.49 | 1.53 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.85 | 1.93 | 1.62 | 1.02 | 0.92 |
| Enterprise Value (Cr.) | 106013.76 | 86549.03 | 71834.36 | 57544.92 | 50957.36 |
| EV / Net Operating Revenue (X) | 2.18 | 1.89 | 1.72 | 2.19 | 2.62 |
| EV / EBITDA (X) | 11.08 | 10.71 | 13.80 | 20.18 | 19.65 |
| MarketCap / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| Retention Ratios (%) | 81.09 | 10.73 | 76.34 | 149.11 | 0.00 |
| Price / BV (X) | 4.90 | 5.58 | 4.78 | 4.71 | 4.24 |
| Price / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| EarningsYield | 0.05 | 0.04 | 0.03 | -0.01 | 0.00 |
After reviewing the key financial ratios for Ashok Leyland Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.56. This value is within the healthy range. It has increased from 8.45 (Mar 24) to 10.56, marking an increase of 2.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.11. This value is within the healthy range. It has increased from 12.29 (Mar 24) to 15.11, marking an increase of 2.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.28. It has increased from 155.95 (Mar 24) to 165.28, marking an increase of 9.33.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.58. This value is within the healthy range. It has increased from 27.53 (Mar 24) to 32.58, marking an increase of 5.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.88. This value is within the healthy range. It has increased from 24.37 (Mar 24) to 28.88, marking an increase of 4.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.54. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 15.54, marking an increase of 1.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 11.41, marking an increase of 2.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For PBDIT Margin (%), as of Mar 25, the value is 19.70. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 19.70, marking an increase of 2.05.
- For PBIT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 15.62 (Mar 24) to 17.47, marking an increase of 1.85.
- For PBT Margin (%), as of Mar 25, the value is 9.40. This value is below the healthy minimum of 10. It has increased from 8.93 (Mar 24) to 9.40, marking an increase of 0.47.
- For Net Profit Margin (%), as of Mar 25, the value is 6.90. This value is within the healthy range. It has increased from 5.85 (Mar 24) to 6.90, marking an increase of 1.05.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.40. This value is below the healthy minimum of 8. It has increased from 5.42 (Mar 24) to 6.40, marking an increase of 0.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.39. This value is within the healthy range. It has decreased from 27.58 (Mar 24) to 25.39, marking a decrease of 2.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.37. This value is within the healthy range. It has decreased from 17.46 (Mar 24) to 15.37, marking a decrease of 2.09.
- For Return On Assets (%), as of Mar 25, the value is 3.80. This value is below the healthy minimum of 5. It has increased from 3.67 (Mar 24) to 3.80, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 2.97. This value exceeds the healthy maximum of 1. It has increased from 2.96 (Mar 24) to 2.97, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 4.06. This value exceeds the healthy maximum of 1. It has decreased from 4.51 (Mar 24) to 4.06, marking a decrease of 0.45.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.74 (Mar 24) to 0.64, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 1.5. It has increased from 1.09 (Mar 24) to 1.29, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 1.14, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.14. This value exceeds the healthy maximum of 8. It has increased from 7.58 (Mar 24) to 12.14, marking an increase of 4.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.90. This value is below the healthy minimum of 20. It has decreased from 89.26 (Mar 24) to 18.90, marking a decrease of 70.36.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.00. This value is below the healthy minimum of 20. It has decreased from 64.99 (Mar 24) to 14.00, marking a decrease of 50.99.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.10. This value exceeds the healthy maximum of 70. It has increased from 10.74 (Mar 24) to 81.10, marking an increase of 70.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.00. This value exceeds the healthy maximum of 70. It has increased from 35.01 (Mar 24) to 86.00, marking an increase of 50.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.71 (Mar 24) to 2.43, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 3. It has decreased from 1.93 (Mar 24) to 1.85, marking a decrease of 0.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 106,013.76. It has increased from 86,549.03 (Mar 24) to 106,013.76, marking an increase of 19,464.73.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.18, marking an increase of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 11.08. This value is within the healthy range. It has increased from 10.71 (Mar 24) to 11.08, marking an increase of 0.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For Retention Ratios (%), as of Mar 25, the value is 81.09. This value exceeds the healthy maximum of 70. It has increased from 10.73 (Mar 24) to 81.09, marking an increase of 70.36.
- For Price / BV (X), as of Mar 25, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.58 (Mar 24) to 4.90, marking a decrease of 0.68.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ashok Leyland Ltd:
- Net Profit Margin: 6.9%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.37% (Industry Average ROCE: 22.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.39% (Industry Average ROE: 25.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.14
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.8 (Industry average Stock P/E: 36.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 4.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.9%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto - LCVs/HCVs | No.1, Sardar Patel Road, Guindy, Chennai (Madras) Tamil Nadu 600032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dheeraj G Hinduja | Executive Chairman |
| Mr. Shenu Agarwal | Managing Director & CEO |
| Mr. Shom Ashok Hinduja | Director |
| Ms. Sanjay K Asher | Director |
| Mr. Manisha Girotra | Director |
| Mr. Gopal Mahadevan | Director |
| Mr. Jose Maria Alapont | Director |
| Mr. Saugata Gupta | Director |
| Dr. C Bhaktavatsala Rao | Director |
| Dr. V Sumantran | Director |
| Mr. Thomas Dauner | Director |
| Mr. Sven Christoph Ennerst | Director |
FAQ
What is the intrinsic value of Ashok Leyland Ltd?
Ashok Leyland Ltd's intrinsic value (as of 15 January 2026) is ₹164.42 which is 12.07% lower the current market price of ₹187.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,09,776 Cr. market cap, FY2025-2026 high/low of ₹192/95.2, reserves of ₹11,996 Cr, and liabilities of ₹85,310 Cr.
What is the Market Cap of Ashok Leyland Ltd?
The Market Cap of Ashok Leyland Ltd is 1,09,776 Cr..
What is the current Stock Price of Ashok Leyland Ltd as on 15 January 2026?
The current stock price of Ashok Leyland Ltd as on 15 January 2026 is ₹187.
What is the High / Low of Ashok Leyland Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ashok Leyland Ltd stocks is ₹192/95.2.
What is the Stock P/E of Ashok Leyland Ltd?
The Stock P/E of Ashok Leyland Ltd is 32.8.
What is the Book Value of Ashok Leyland Ltd?
The Book Value of Ashok Leyland Ltd is 21.4.
What is the Dividend Yield of Ashok Leyland Ltd?
The Dividend Yield of Ashok Leyland Ltd is 1.67 %.
What is the ROCE of Ashok Leyland Ltd?
The ROCE of Ashok Leyland Ltd is 14.3 %.
What is the ROE of Ashok Leyland Ltd?
The ROE of Ashok Leyland Ltd is 28.8 %.
What is the Face Value of Ashok Leyland Ltd?
The Face Value of Ashok Leyland Ltd is 1.00.